Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase
Farah Anjum, Taj Mohammad, Abdulraheem Ali Almalki, et al.
OMICS A Journal of Integrative Biology (2021) Vol. 25, Iss. 9, pp. 580-590
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Identification of Phytoconstituents as Potent Inhibitors of Casein Kinase-1 Alpha Using Virtual Screening and Molecular Dynamics Simulations
Alaa Shafie, Shama Khan, Zehra, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2157-2157
Open Access | Times Cited: 38
Identifying potential inhibitors of phosphatidylinositol 4,5-bisphosphate 3-kinase: Molecular dynamic insights into the interaction and inhibitory mechanism
Taj Mohammad, Afzal Hussain, Mohamed F. Alajmi, et al.
Chemical Physics Impact (2024) Vol. 8, pp. 100458-100458
Open Access | Times Cited: 6
Targeting Filamenting temperature-sensitive mutant Z (FtsZ) with bioactive phytoconstituents: An emerging strategy for antibacterial therapy
Bader S. Alotaibi
PLoS ONE (2023) Vol. 18, Iss. 8, pp. e0290852-e0290852
Open Access | Times Cited: 11
Identification of High-Affinity Inhibitors of TANK-Binding Kinase 1 (TBK1): A Promising Frontier for Controlling Inflammatory Signaling in Cancer
Deeba Shamim Jairajpuri, Taj Mohammad, Afzal Hussain, et al.
Discovery Medicine (2024) Vol. 36, Iss. 180, pp. 129-129
Open Access | Times Cited: 4
Integrated virtual screening and MD simulation study to discover potential inhibitors of Lyn-kinase: targeting cancer therapy
Md. Imtaiyaz Hassan, Darakshan Anjum, Taj Mohammad, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 20, pp. 10558-10568
Closed Access | Times Cited: 19
Bioactive Phytoconstituents as Potent Inhibitors of Tyrosine-Protein Kinase Yes (YES1): Implications in Anticancer Therapeutics
Chunmin Yang, Afsar Alam, Fahad A. Alhumaydhi, et al.
Molecules (2022) Vol. 27, Iss. 10, pp. 3060-3060
Open Access | Times Cited: 18
Cinnamomum zeylanicum Extract and its Bioactive Component Cinnamaldehyde Show Anti-Tumor Effects via Inhibition of Multiple Cellular Pathways
Sadhna Aggarwal, Kanchan Bhadana, Baldeep Singh, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 18
A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma
Sarfraz Ahmed, Mohammad Mobashir, Lamya Ahmed Al‐Keridis, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Structure-guided screening identified bioactive phytoconstituents Hernandonine and Anolobine as potential inhibitors of dual specificity protein kinase CLK1
Sumaiya Khan, Arunabh Choudhury, Taj Mohammad, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Exploring bioactive phytoconstituents as USP21 inhibitors for therapeutic development against cancer
Saleha Anwar, M. S. Khan, Dharmendra Kumar Yadav, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Virtual screening of potential inhibitor against breast cancer-causing estrogen receptor alpha (ERα): molecular docking and dynamic simulations
Shabbir Muhammad, Afsheen Saba, Rasheed Ahmad Khera, et al.
Molecular Simulation (2022) Vol. 48, Iss. 13, pp. 1163-1174
Closed Access | Times Cited: 16
Identifying Isoononin and Candidissiol as Rho-associated protein kinase 1 (ROCK1) inhibitors: a combined virtual screening and MD simulation approach
Bader S. Alotaibi, Jatin Joshi, Mohammad Raghibul Hasan, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 14, pp. 6749-6758
Closed Access | Times Cited: 16
Structure-Guided Approach to Discover Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy
Mohd Adnan, Anas Shamsi, Abdelbaset Mohamed Elasbali, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13172-13172
Open Access | Times Cited: 14
Discovering Tuberosin and Villosol as Potent and Selective Inhibitors of AKT1 for Therapeutic Targeting of Oral Squamous Cell Carcinoma
Mohd Adnan, Deeba Shamim Jairajpuri, Muskan Chaddha, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 7, pp. 1083-1083
Open Access | Times Cited: 11
Searching for Novel Anaplastic Lymphoma Kinase Inhibitors: Structure-Guided Screening of Natural Compounds for a Tyrosine Kinase Therapeutic Target in Cancers
Mohd Adnan, Saadgee Koli, Taj Mohammad, et al.
OMICS A Journal of Integrative Biology (2022) Vol. 26, Iss. 8, pp. 461-470
Closed Access | Times Cited: 11
Daemonorops draco Blume Induces Apoptosis Against Acute Myeloid Leukemia Cells via Regulation of the miR-216b/c-Jun
Moon Nyeo Park, Hee Won Jeon, Md. Ataur Rahman, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Identification of natural product-based effective inhibitors of spleen tyrosine kinase (SYK) through virtual screening and molecular dynamics simulation approaches
Tufail Ali, Farah Anjum, Arunabh Choudhury, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 7, pp. 3459-3471
Closed Access | Times Cited: 5
Applications of some advanced sequencing, analytical, and computational approaches in medicinal plant research: a review
Dhananjay Singh, Nishu Mittal, Swati Verma, et al.
Molecular Biology Reports (2023) Vol. 51, Iss. 1
Closed Access | Times Cited: 4
Photoresponsive ‘Chemo-Free’ Phytotherapy: Formulation Development For the Treatment of Triple-Negative Breast Cancer
Neha Maheshwari, Mukesh C. Sharma
Nanomedicine (2024) Vol. 19, Iss. 1, pp. 5-24
Closed Access | Times Cited: 1
Exploring phytochemical inhibitors of protein kinase C alpha for therapeutic targeting of Alzheimer's disease
AA Aazad, Arunabh Choudhury, Afzal Hussain, et al.
Journal of Alzheimer s Disease (2024)
Closed Access | Times Cited: 1
Discovery of new inhibitors of Mycobacterium tuberculosis EPSP synthase - A computational study
Bruno Rampanelli Dahmer, Eduardo Miranda Ethur, Luís Fernando Saraiva Macedo Timmers
Journal of Molecular Graphics and Modelling (2023) Vol. 121, pp. 108404-108404
Closed Access | Times Cited: 3
Identifying β-secretase 1 (BACE1) inhibitors from plant-based compounds: an approach targeting Alzheimer’s therapeutics employing molecular docking and dynamics simulation
Mohammed Alrouji, Fahad A. Alhumaydhi, Waleed Al Abdulmonem, et al.
Molecular Diversity (2023)
Closed Access | Times Cited: 3
Identifying bioactive phytoconstituents as C-terminal Src kinase inhibitors: a virtual screening and molecular simulation approach
Elyasa Mustafa Elfaki, Hassan H. Alhassan, Mehnaz Kamal, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 22, pp. 13415-13424
Closed Access | Times Cited: 2
Discovering potential inhibitors of Raf proto-oncogene serine/threonine kinase 1: a virtual screening approach towards anticancer drug development
Afsha Khan, Mohamed Ahmed Bealy, Bandar Alharbi, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 4, pp. 1846-1857
Closed Access | Times Cited: 2
Identification of potential inhibitors of tropomyosin receptor kinase B targeting CNS-related disorders and cancers
Mohammed Ageeli Hakami, Bader S. Alotaibi, Ali Hazazi, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 6, pp. 2965-2975
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top